• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素样生长因子 1 受体受舒尼替尼下调诱导 MDM2 依赖性泛素化。

IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination.

机构信息

Department of Thoracic Surgery, Provincial Hospital Affiliated to Shandong University, Shandong University, Jinan 250021, China.

出版信息

FEBS Open Bio. 2011 Dec 27;2:1-5. doi: 10.1016/j.fob.2011.12.001. Print 2012.

DOI:10.1016/j.fob.2011.12.001
PMID:23650573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3642090/
Abstract

The insulin like growth factor receptor subtype 1(IGF-1R) plays an important role in cancers transformation and progression. The aim is to investigate the effects of sunitinib on IGF-1R cell signaling transduction, especially on receptor phosphorylation and ubiquitination. In HEK293 cells, IGF-1R signaling pathways are activated in response to IGF-1, which induces obvious phosphorylations of receptor tyrosine and Akt, ERK. However, the phosphorylations of receptor tyrosine, Akt and ERK were significant inhibited by sunitinib. We found that both IGF-1 and sunitinib obviously down regulated the IGF-1R expression. For analysis the ubiquitination, HEK293 cells were simulated with 100 ng/ml IGF-1 or 10 nM sunitinib for 10 min after serum starvation for 24 h. Both IGF-1 and sunitinib could obviously induce the IGF-1R ubiquitination at 10 min compared with control (only serum free, no stimulation), indicating IGF-1 and sunitinib down-regulate the IGF-1R by increasing the receptor degradation through ubiquitination dependent proteasome pathway. We also found that MDM2 combined to IGF-1R in response to sunitinib stimulation. To confirm it, HEK293 cells were transfected with human HA-MDM2 (+MDM2) or siRNA to MDM2 (-MDM2). Following 24 h serum starvation, cells were stimulated with 10 nM sunitinib for 10 min. In over-expressed MDM2 cells, IGF-1R was more ubiquitinated than that in mock-transfected cells (control), and no ubiquitination in -MDM2 cells. These results mean that sunitinib mediates ubiquitination of IGF-1R dependent on MDM2. In summary, sunitinib could block signaling transduction and mediate degradation of IGF-1R.

摘要

胰岛素样生长因子受体亚型 1(IGF-1R)在癌症的转化和进展中起着重要作用。本研究旨在探讨舒尼替尼对 IGF-1R 细胞信号转导的影响,特别是对受体磷酸化和泛素化的影响。在 HEK293 细胞中,IGF-1 激活 IGF-1R 信号通路,导致受体酪氨酸和 Akt、ERK 的明显磷酸化。然而,舒尼替尼显著抑制受体酪氨酸、Akt 和 ERK 的磷酸化。我们发现 IGF-1 和舒尼替尼均明显下调 IGF-1R 的表达。为了分析泛素化,在血清饥饿 24 小时后,用 100ng/ml IGF-1 或 10nM 舒尼替尼刺激 HEK293 细胞 10 分钟。与对照组(仅无血清,无刺激)相比,IGF-1 和舒尼替尼均能明显诱导 10 分钟时 IGF-1R 的泛素化,表明 IGF-1 和舒尼替尼通过增加受体降解来下调 IGF-1R,从而通过泛素化依赖的蛋白酶体途径。我们还发现 MDM2 在舒尼替尼刺激下与 IGF-1R 结合。为了证实这一点,用 HA-MDM2(+MDM2)或 MDM2 小干扰 RNA(-MDM2)转染 HEK293 细胞。血清饥饿 24 小时后,用 10nM 舒尼替尼刺激细胞 10 分钟。在过表达 MDM2 的细胞中,IGF-1R 的泛素化程度高于 mock 转染细胞(对照组),而 -MDM2 细胞中没有泛素化。这些结果表明,舒尼替尼介导 IGF-1R 的泛素化依赖于 MDM2。总之,舒尼替尼可阻断 IGF-1R 的信号转导并介导其降解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/792996122552/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/63803610a0d8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/b3777650ccb9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/336458b27b1d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/792996122552/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/63803610a0d8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/b3777650ccb9/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/336458b27b1d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6ed8/3642090/792996122552/gr4.jpg

相似文献

1
IGF-1 receptor is down-regulated by sunitinib induces MDM2-dependent ubiquitination.胰岛素样生长因子 1 受体受舒尼替尼下调诱导 MDM2 依赖性泛素化。
FEBS Open Bio. 2011 Dec 27;2:1-5. doi: 10.1016/j.fob.2011.12.001. Print 2012.
2
Insulin-like growth factor type-I receptor-dependent phosphorylation of extracellular signal-regulated kinase 1/2 but not Akt (protein kinase B) can be induced by picropodophyllin.鬼臼苦素可诱导胰岛素样生长因子I型受体依赖的细胞外信号调节激酶1/2磷酸化,但不能诱导Akt(蛋白激酶B)磷酸化。
Mol Pharmacol. 2008 Mar;73(3):930-9. doi: 10.1124/mol.107.040014. Epub 2007 Dec 10.
3
Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor.Mdm2 依赖性的胰岛素样生长因子 1 受体泛素化及降解
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8247-52. doi: 10.1073/pnas.1431613100. Epub 2003 Jun 23.
4
Role of ubiquitination in IGF-1 receptor signaling and degradation.泛素化在 IGF-1 受体信号转导和降解中的作用。
PLoS One. 2007 Apr 4;2(4):e340. doi: 10.1371/journal.pone.0000340.
5
{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.β-抑制蛋白作为MDM2 E3连接酶的衔接蛋白,对于胰岛素样生长因子-1受体的泛素化和下调至关重要。
J Biol Chem. 2005 Jul 1;280(26):24412-9. doi: 10.1074/jbc.M501129200. Epub 2005 May 3.
6
Beta-arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression.β-抑制蛋白和Mdm2介导胰岛素样生长因子-1受体刺激的细胞外信号调节激酶激活和细胞周期进程。
J Biol Chem. 2007 Apr 13;282(15):11329-38. doi: 10.1074/jbc.M611526200. Epub 2007 Feb 15.
7
Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.鉴定c-Cbl作为胰岛素样生长因子-I受体的一种新连接酶,其在受体泛素化和内吞作用中具有与Mdm2不同的作用。
Cancer Res. 2008 Jul 15;68(14):5669-77. doi: 10.1158/0008-5472.CAN-07-6364.
8
Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells.胰岛素样生长因子-1受体信号传导中的年龄相关差异调节血管平滑肌细胞中的Akt/FOXO3a和ERK/Fos通路。
J Cell Physiol. 2008 Nov;217(2):377-87. doi: 10.1002/jcp.21507.
9
Elevated insulin-like growth factor 1 receptor signaling induces antiestrogen resistance through the MAPK/ERK and PI3K/Akt signaling routes.胰岛素样生长因子 1 受体信号的升高通过 MAPK/ERK 和 PI3K/Akt 信号通路诱导抗雌激素耐药。
Breast Cancer Res. 2011 May 19;13(3):R52. doi: 10.1186/bcr2883.
10
β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma.β-arrestin 偏向激动作用是胰岛素样生长因子 1 受体靶向抗体在尤文肉瘤中发挥作用的主要机制。
Proc Natl Acad Sci U S A. 2012 Dec 11;109(50):20620-5. doi: 10.1073/pnas.1216348110. Epub 2012 Nov 27.

引用本文的文献

1
Tumor-associated macrophages/C-X-C motif chemokine ligand 1 promotes breast cancer autophagy-mediated chemoresistance via IGF1R/STAT3/HMGB1 signaling.肿瘤相关巨噬细胞/C-X-C 基序趋化因子配体 1 通过 IGF1R/STAT3/HMGB1 信号通路促进乳腺癌自噬介导的化疗耐药性。
Cell Death Dis. 2024 Oct 11;15(10):743. doi: 10.1038/s41419-024-07123-5.
2
Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling.胍那苄通过抑制 GADD34 介导的自噬信号来增强胶质母细胞瘤细胞对舒尼替尼的敏感性。
Neurotherapeutics. 2021 Apr;18(2):1371-1392. doi: 10.1007/s13311-020-00961-z. Epub 2021 Jan 6.
3
IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons.

本文引用的文献

1
Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.鉴定c-Cbl作为胰岛素样生长因子-I受体的一种新连接酶,其在受体泛素化和内吞作用中具有与Mdm2不同的作用。
Cancer Res. 2008 Jul 15;68(14):5669-77. doi: 10.1158/0008-5472.CAN-07-6364.
2
IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer.胰岛素样生长因子(IGF)轴基因表达模式可预测上皮性卵巢癌的生存率。
Endocr Relat Cancer. 2007 Sep;14(3):781-90. doi: 10.1677/ERC-06-0073.
3
Molecular basis for sunitinib efficacy and future clinical development.
IGF1R 调节运动神经元中信号内体的逆行轴突运输。
EMBO Rep. 2020 Mar 4;21(3):e49129. doi: 10.15252/embr.201949129. Epub 2020 Feb 7.
4
EGF and IGF1 affect sunitinib activity in BP-NEN: new putative targets beyond VEGFR?表皮生长因子(EGF)和胰岛素样生长因子1(IGF1)对舒尼替尼在胰腺神经内分泌肿瘤(BP-NEN)中的活性产生影响:除血管内皮生长因子受体(VEGFR)之外的新潜在靶点?
Endocr Connect. 2019 Jun 1;8(6):680-690. doi: 10.1530/EC-19-0192.
5
Tanshinone IIA Attenuates Insulin Like Growth Factor 1 -Induced Cell Proliferation in PC12 Cells through the PI3K/Akt and MEK/ERK Pathways.丹参酮 IIA 通过 PI3K/Akt 和 MEK/ERK 通路抑制 IGF-1 诱导的 PC12 细胞增殖。
Int J Mol Sci. 2018 Sep 12;19(9):2719. doi: 10.3390/ijms19092719.
6
The early effect of sunitinib on insulin clearance in patients with metastatic renal cell carcinoma.舒尼替尼对转移性肾细胞癌患者胰岛素清除率的早期影响。
Br J Clin Pharmacol. 2016 Apr;81(4):768-72. doi: 10.1111/bcp.12797. Epub 2016 Jan 14.
7
Paracrine factors of human fetal MSCs inhibit liver cancer growth through reduced activation of IGF-1R/PI3K/Akt signaling.人胎儿间充质干细胞的旁分泌因子通过降低IGF-1R/PI3K/Akt信号通路的激活来抑制肝癌生长。
Mol Ther. 2015 Apr;23(4):746-56. doi: 10.1038/mt.2015.13. Epub 2015 Jan 26.
8
Transcriptome analysis in prenatal IGF1-deficient mice identifies molecular pathways and target genes involved in distal lung differentiation.产前 IGF1 缺陷型小鼠的转录组分析鉴定了参与远端肺分化的分子途径和靶基因。
PLoS One. 2013 Dec 31;8(12):e83028. doi: 10.1371/journal.pone.0083028. eCollection 2013.
舒尼替尼疗效的分子基础及未来临床发展
Nat Rev Drug Discov. 2007 Sep;6(9):734-45. doi: 10.1038/nrd2380.
4
Spectrum of activity and mechanism of action of VEGF/PDGF inhibitors.血管内皮生长因子/血小板衍生生长因子抑制剂的活性谱及作用机制
Cancer Control. 2007 Jul;14(3):285-94. doi: 10.1177/107327480701400312.
5
An orally administered multitarget tyrosine kinase inhibitor, SU11248, is a novel potent inhibitor of thyroid oncogenic RET/papillary thyroid cancer kinases.口服多靶点酪氨酸激酶抑制剂SU11248是一种新型强效甲状腺致癌性RET/甲状腺乳头状癌激酶抑制剂。
J Clin Endocrinol Metab. 2006 Oct;91(10):4070-6. doi: 10.1210/jc.2005-2845. Epub 2006 Jul 18.
6
Overview of the IGF-I system.胰岛素样生长因子-I系统概述。
Horm Res. 2006;65 Suppl 1:3-8. doi: 10.1159/000090640. Epub 2006 Mar 2.
7
{beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.β-抑制蛋白作为MDM2 E3连接酶的衔接蛋白,对于胰岛素样生长因子-1受体的泛素化和下调至关重要。
J Biol Chem. 2005 Jul 1;280(26):24412-9. doi: 10.1074/jbc.M501129200. Epub 2005 May 3.
8
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts.一种重组人源化抗胰岛素样生长因子I型受体抗体(h7C10)可增强长春瑞滨和抗表皮生长因子受体疗法对人癌异种移植瘤的抗肿瘤活性。
Int J Cancer. 2005 Jan 10;113(2):316-28. doi: 10.1002/ijc.20543.
9
Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth.环木脂素作为胰岛素样生长因子-1受体抑制剂及对恶性细胞生长的影响
Cancer Res. 2004 Jan 1;64(1):236-42. doi: 10.1158/0008-5472.can-03-2522.
10
SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model.在实验性乳腺癌骨转移模型中,SU11248可抑制肿瘤生长及CSF-1R依赖性骨溶解。
Clin Exp Metastasis. 2003;20(8):757-66. doi: 10.1023/b:clin.0000006873.65590.68.